Built To Serve
We’ve developed a reputation based on trust, responsiveness, and strategic guidance over decades of serving life sciences and healthcare organizations. We believe in the companies we partner with, and measure our success in how we’re able to help them achieve their short and long-term financial goals.
Oxford’s greatest asset is its team. They have deep industry knowledge that allows them to think and act strategically with their clients, and to do so in a timely manner. They also care about relationship building, and that has greatly enhanced our ability to work well together.

Peter Lawrence
President & COO, ArQule, Inc.Oxford Finance is one of the premier venture lending groups serving the life sciences community. Their continuity in the marketplace, as well as their professional and collaborative approach to transactions, makes them a logical go-to source for CFOs.

John Schmid
Chief Financial Officer, Auspex PharmaceuticalsCadence Pharmaceuticals and the entire senior management team at Oxford have developed a comfortable and deep working relationship over the years. Oxford has been very responsive to our financing requirements, and we can also count on them for timely execution.

William LaRue
Senior Vice President, Chief Financial Officer & Assistant Secretary, Cadence PharmaceuticalsOxford is well known and highly regarded throughout the industry. The team was extremely knowledgeable, professional and responsive. They listened, took the time to understand our company’s business model and value drivers, and focused on what is important to IDEV Technologies.

Bill Burke
Executive Vice President & Chief Financial Officer, IDEV TechnologiesI have a long track record with Oxford, and have found them very easy to work with and competitively priced. They know the life sciences space, and have the flexibility and patience needed to support start-ups through the various stages of development.

Richard Buchholz
Chief Financial Officer, Inspire Medical SystemsOxford has been in the life sciences field for a long time, and they have a thorough understanding of companies in this space. They understand business risks and that projections and final numbers may differ. The funds we received from Oxford enabled us to extend our runway at a minimal cost of capital dilution.

Kevin Cousins
Vice President & Chief Financial Officer, Sequent MedicalOxford is a great choice for a lender. They delivered a financing structure that was strategically useful and tailored to our business plan. Oxford is a reliable and supportive partner that provided the financial strength we needed during our transition to a public company.
